Analytical Cannabis speaks to the extractors using automated solutions to boost their productivity.
While these psychedelics users did tend to report an increased belief in the paranormal after their trip, superstitious beliefs largely remained unchained.
The products were sold in dispensaries between September 17 and October 12.
The first-of-its-kind phase 3 trial will soon begin in the UK to test whether ketamine can help treat patients with alcohol use disorder.
Of particular concern are edible cannabis products, the researchers say, which may be marketed in ways that make them more attractive to youth.
CBD oils do not improve patients’ ratings of pain, depression, anxiety, or quality of life, a new trial of palliative care patients with advanced cancer has found.